Contact

All Stories

  1. GPCRs as targets for flavonoids in cancer cells: new options for intervention

    Article • Exploration of Targeted Anti-tumor Therapy, August 2024, Open Exploration Publishing

    Dr. Katrin Sak

  2. Diabetes and cancer: two epidemic diseases requiring an opposite therapeutic approach to target cells

    Article • May 2024, Open Exploration Publishing

    Dr. Katrin Sak

  3. The low expression of matrix metalloproteinases: a key to longevity?

    Article • Exploration of Medicine, April 2024, Open Exploration Publishing

    Dr. Katrin Sak

  4. High intake of sunflower seeds and low mortality from Alzheimer’s disease and dementia: is there a correlation?

    Article • March 2024, Open Exploration Publishing

    Dr. Katrin Sak

  5. Licorice (Glycyrrhiza Glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects [Corrigendum]

    Article • OncoTargets and Therapy, January 2024, Taylor & Francis

    Dr. Katrin Sak

  6. Fundamentals of Flavonoids and Their Health Benefits

    Article • January 2024, Nova Science Publishers, Inc.

    Dr. Katrin Sak

  7. Could unpublishing negative results be harmful to the general public?

    Article • Journal of Translational Internal Medicine, December 2023, De Gruyter

    Dr. Katrin Sak

  8. Could flavonoid aglycones prevent the absorption of flavonoid glycosides by inhibiting sodium-dependent glucose transporter-1 in the small intestine?

    Article • August 2023, Open Exploration Publishing

    Dr. Katrin Sak

  9. Role of Flavonoids as Potential Plant Fungicides in Preventing Human Carcinogenesis: A Short Communication

    Article • Bioactivities, August 2023, Pandawa Institute

    Dr. Katrin Sak

  10. Ginnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential

    Article • Exploration of Targeted Anti-tumor Therapy, April 2023, Open Exploration Publishing

    Dr. Katrin Sak, Dr Bikram Jit Singh

  11. Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements

    Article • Pharmaceutics, February 2023, MDPI AG

    Dr. Katrin Sak

  12. Autophagy Induction by Scutellaria Flavones in Cancer: Recent Advances

    Article • Pharmaceuticals, February 2023, MDPI AG

    Dr. Katrin Sak

  13. Recommendation to Consume Plant Products for Their Health Benefits May Take a Different Perspective with Global Warming

    Article • Current Nutrition & Food Science, January 2023, Bentham Science Publishers

    Dr. Katrin Sak

  14. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends

    Article • Biomolecules, December 2022, MDPI AG

    Dr. Katrin Sak

  15. Phloretin, as a Potent Anticancer Compound: From Chemistry to Cellular Interactions

    Article • Molecules, December 2022, MDPI AG

    Dr. Katrin Sak

  16. Colonic Degradation as Reverse Process to Flavone Biosynthesis in Plants: Similarities and Differences

    Article • Drug Metabolism and Bioanalysis Letters, November 2022, Bentham Science Publishers

    Dr. Katrin Sak

  17. Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone

    Article • Pharmaceuticals, November 2022, MDPI AG

    Dr. Katrin Sak

  18. Ferulic Acid: A Natural Phenol That Inhibits Neoplastic Events through Modulation of Oncogenic Signaling

    Article • Molecules, November 2022, MDPI AG

    Dr. Katrin Sak

  19. Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects

    Article • OncoTargets and Therapy, November 2022, Taylor & Francis

    Dr. Katrin Sak

  20. Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives

    Article • Cancers, October 2022, MDPI AG

    Dr. Katrin Sak, Prof Mukerrem B Yerer

  21. Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, October 2022, Springer Science + Business Media

    Dr. Katrin Sak

  22. Dietary Flavonoids with Catechol Moiety Inhibit Anticancer Action of Bortezomib: What about the other Boronic Acid-Based Drugs?

    Article • Current Cancer Drug Targets, October 2022, Bentham Science Publishers

    Dr. Katrin Sak

  23. Anticancer action of plant products: changing stereotyped attitudes

    Article • August 2022, Open Exploration Publishing

    Dr. Katrin Sak

  24. Recent Advances in Immunotherapy for the Treatment of Malignant Melanoma

    Article • Current Pharmaceutical Design, August 2022, Bentham Science Publishers

    Dr. Katrin Sak

  25. Editorial: Current Aspects in Chemopreventive Strategies, Volume II

    Article • Frontiers in Pharmacology, July 2022, Frontiers

    Dr. Katrin Sak, Prof Mukerrem B Yerer

  26. Metal nanoparticles in cancer: from synthesis and metabolism to cellular interactions

    Article • Journal of Nanostructure in Chemistry, June 2022, Springer Science + Business Media

    Dr. Katrin Sak

  27. Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement

    Article • Seminars in Cancer Biology, May 2022, Elsevier

    Dr. Katrin Sak

  28. STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation

    Article • Molecular Biology Reports, April 2022, Springer Science + Business Media

    Dr. Katrin Sak, Prof Mukerrem B Yerer

  29. Gallic Acid: A Dietary Polyphenol that Exhibits Anti-neoplastic Activities by Modulating Multiple Oncogenic Targets

    Article • Anti-Cancer Agents in Medicinal Chemistry, February 2022, Bentham Science Publishers

    Dr. Katrin Sak

  30. How Plant Flavonoids Affect the Outcome of Hormonal and Biological Cancer Therapies: A Handbook for Doctors and Patients

    Article • January 2022, Nova Science Publishers, Inc.

    Dr. Katrin Sak

  31. Galangin: A metabolite that suppresses anti-neoplastic activities through modulation of oncogenic targets

    Article • Experimental Biology and Medicine, December 2021, SAGE Publications

    Dr. Katrin Sak

  32. Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines

    Article • Frontiers in Cellular and Infection Microbiology, December 2021, Frontiers

    Dr. Katrin Sak

  33. Anti-Inflammatory and Anticancer Properties of Birch Bark-Derived Betulin: Recent Developments

    Article • Plants, December 2021, MDPI AG

    Dr. Katrin Sak, Prof Mukerrem B Yerer

  34. Molecular mechanisms underlying chemopreventive potential of butein: Current trends and future perspectives

    Article • Chemico-Biological Interactions, December 2021, Elsevier

    Dr. Katrin Sak

  35. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance

    Article • Seminars in Cancer Biology, August 2021, Elsevier

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  36. NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target

    Article • Critical Reviews in Oncology/Hematology, August 2021, Elsevier

    Dr. Katrin Sak

  37. Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets

    Article • Toxicology in Vitro, June 2021, Elsevier

    Dr. Katrin Sak

  38. Deguelin targets multiple oncogenic signaling pathways to combat human malignancies

    Article • Pharmacological Research, April 2021, Elsevier

    Dr. Katrin Sak

  39. Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential

    Article • Anti-Cancer Agents in Medicinal Chemistry, February 2021, Bentham Science Publishers

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  40. Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements

    Article • 3 Biotech, February 2021, Springer Science + Business Media

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  41. Editorial: Current Aspects in Chemopreventive Strategies

    Article • Frontiers in Pharmacology, January 2021, Frontiers

    Dr. Katrin Sak, Prof Mukerrem B Yerer

  42. Editorial: Current Aspects in Chemopreventive Strategies

    Article • January 2021, Frontiers

    Prof Mukerrem B Yerer, Dr. Katrin Sak

  43. Role of semisynthetic flavonoids on cytotoxic chemotherapy—Dual benefit to cancer patients?

    Article • January 2021, Elsevier

    Dr. Katrin Sak

  44. Nanoformulations of Coumarins and the Hybrid Molecules of Coumarins with Potential Anticancer Effects

    Article • Anti-Cancer Agents in Medicinal Chemistry, October 2020, Bentham Science Publishers

    Dr. Katrin Sak, Prof Mukerrem B Yerer, Dr. Hardeep Singh Tuli, Dr ajay sharma

  45. Baicalein: A metabolite with promising antineoplastic activity

    Article • Life Sciences, October 2020, Elsevier

    Dr. Katrin Sak

  46. Antioxidant Phytoconstituents From Onosma bracteata Wall. (Boraginaceae) Ameliorate the CCl4 Induced Hepatic Damage: In Vivo Study in Male Wistar Rats

    Article • Frontiers in Pharmacology, August 2020, Frontiers

    Dr. Katrin Sak

  47. COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact

    Article • Current Pharmacology Reports, July 2020, Springer Science + Business Media

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  48. Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells

    Article • Biomedicines, April 2020, MDPI AG

    Dr. Katrin Sak

  49. Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements

    Article • Experimental Biology and Medicine, February 2020, SAGE Publications

    Gautam Sethi, Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  50. Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances

    Article • Frontiers in Pharmacology, December 2019, Frontiers

    Dr. Katrin Sak

  51. Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

    Article • Biomolecules, November 2019, MDPI AG

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak, Prof Mukerrem B Yerer

  52. Radiosensitizing Potential of Curcumin in Different Cancer Models

    Article • Nutrition and Cancer, October 2019, Taylor & Francis

    Dr. Katrin Sak

  53. A hypothetical approach on gender differences in cancer diagnosis

    Article • Journal of Translational Internal Medicine, October 2019, De Gruyter

    Dr. Katrin Sak

  54. Probing into Therapeutic Anti-cancer Potential of Apigenin: Recent Trends and Future Directions

    Article • Recent Patents on Inflammation & Allergy Drug Discovery, August 2019, Bentham Science Publishers

    Dr ajay sharma, Dr. Katrin Sak

  55. Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

    Article • Seminars in Cancer Biology, August 2019, Elsevier

    Dr ajay sharma, Dr. Hardeep Singh Tuli, Dr. Katrin Sak, Prof Mukerrem B Yerer

  56. Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential

    Article • Biomolecules, May 2019, MDPI AG

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak, Prof Mukerrem B Yerer

  57. Role of Reactive Oxygen Species in Cancer Progression

    Article • Current Pharmacology Reports, February 2019, Springer Science + Business Media

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  58. Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements

    Article • International Journal of Molecular Sciences, February 2019, MDPI AG

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak, Prof Mukerrem B Yerer

  59. Polymorphisms in COMT and SULT1A1 Genes and Chronic Lymphocytic Leukemia Risk in Estonia

    Article • Eurasian Journal of Medicine and Oncology, January 2019, Kare Publishing

    Dr. Katrin Sak

  60. Suppression of Taxanes Cytotoxicity by Citrus Flavonoid Hesperetin in PPC-1 Human Prostate Cancer Cells

    Article • Anticancer Research, November 2018, International Institute of Anticancer Research

    Dr. Katrin Sak

  61. P1.15-11 Lung Cancer as One of Multiple Cancers: A Population-Based Study in Estonia 1995-2015

    Article • Journal of Thoracic Oncology, October 2018, Elsevier

    Dr. Katrin Sak

  62. Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function

    Article • Journal of Functional Foods, September 2018, Elsevier

    Dr ajay sharma, Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  63. Molecular targets of celastrol in cancer: Recent trends and advancements

    Article • Critical Reviews in Oncology/Hematology, August 2018, Elsevier

    Dr ajay sharma, Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  64. Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy

    Article • Life Sciences, February 2018, Elsevier

    Dr ajay sharma, Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  65. Therapeutic charm of quercetin and its derivatives: a review of research and patents

    Article • Pharmaceutical Patent Analyst, December 2017, Future Science

    Dr. Hardeep Singh Tuli, Dr ajay sharma, Dr. Katrin Sak

  66. Cytotoxic action of methylquercetins in human lung adenocarcinoma cells

    Article • Oncology Letters, November 2017, Spandidos Publications

    Dr. Katrin Sak

  67. Intake of Individual Flavonoids and Risk of Carcinogenesis: Overview of Epidemiological Evidence

    Article • Nutrition and Cancer, October 2017, Taylor & Francis

    Dr. Katrin Sak

  68. Role of Flavonoids in the Prevention of Gynecological Cancers: Epidemiological Clues

    Article • Current Women s Health Reviews, August 2017, Bentham Science Publishers

    Dr. Katrin Sak

  69. Kaempferol – A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements

    Article • Journal of Functional Foods, March 2017, Elsevier

    Dr. Hardeep Singh Tuli, Dr ajay sharma, Dr. Katrin Sak

  70. Mechanistic insight into carnosol-mediated pharmacological effects: Recent trends and advancements

    Article • Life Sciences, January 2017, Elsevier

    Dr. Hardeep Singh Tuli, Dr ajay sharma, Dr. Katrin Sak

  71. Anticancer Action of Sulfated Flavonoids as Phase II Metabolites

    Article • January 2017, Elsevier

    Dr. Katrin Sak

  72. Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids

    Article • Current Genomics, December 2016, Bentham Science Publishers

    Dr. Katrin Sak

  73. The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols

    Article • Drug Metabolism Reviews, November 2016, Taylor & Francis

    Dr. Katrin Sak

  74. Molecular mechanisms of action of quercetin in cancer: recent advances

    Article • Tumor Biology, July 2016, Springer Science + Business Media

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  75. Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids

    Article • Current Drug Metabolism, May 2016, Bentham Science Publishers

    Dr. Katrin Sak

  76. Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives

    Article • Life Sciences, March 2016, Elsevier

    Dr. Hardeep Singh Tuli, Dr. Katrin Sak

  77. Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines

    Article • Food & Function, January 2016, Royal Society of Chemistry

    Dr. Katrin Sak

  78. Nanotechnological approach to improve the bioavailability of dietary flavonoids with chemopreventive and anticancer properties

    Article • January 2016, Elsevier

    Dr. Katrin Sak

  79. Chemomodulating Effects of Flavonoids in Human Leukemia Cells

    Article • Anti-Cancer Agents in Medicinal Chemistry, September 2015, Bentham Science Publishers

    Dr. Katrin Sak

  80. Distinctive Genetic Profile With IDH1, TP53 , and MLH1 Mutations in a Radiation-Induced Anaplastic Astrocytoma

    Article • Pediatric Blood & Cancer, July 2015, Wiley

    Dr. Katrin Sak

  81. Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells

    Article • Asian Pacific Journal of Cancer Prevention, July 2015, Asian Pacific Organization for Cancer Prevention

    Dr. Katrin Sak

  82. Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells

    Article • Current Stem Cell Research & Therapy, April 2015, Bentham Science Publishers

    Dr. Katrin Sak

  83. In vitro Cytotoxic Activity of Flavonoids on Human Ovarian Cancer Cell Lines

    Article • Cancer Science & Research Open Access, January 2015, Symbiosis Group

    Dr. Katrin Sak

  84. Characteristic Features of Cytotoxic Activity of Flavonoids on Human Cervical Cancer Cells

    Article • Asian Pacific Journal of Cancer Prevention, October 2014, Asian Pacific Organization for Cancer Prevention

    Dr. Katrin Sak

  85. A new lignan glycoside from the aerial parts and cytotoxic investigation of Uvaria rufa

    Article • Natural Product Research, October 2014, Taylor & Francis

    Phan Van Kiem, Dr. Katrin Sak

  86. Dependence of DPPH Radical Scavenging Activity of Dietary Flavonoid Quercetin on Reaction Environment

    Article • Mini-Reviews in Medicinal Chemistry, June 2014, Bentham Science Publishers

    Dr. Katrin Sak

  87. Estonian folk traditional experiences on natural anticancer remedies: From past to the future

    Article • Pharmaceutical Biology, February 2014, Taylor & Francis

    Dr. Katrin Sak

  88. Cytotoxicity of dietary flavonoids on different human cancer types

    Article • Pharmacognosy Reviews, January 2014, EManuscript Services

    Dr. Katrin Sak

  89. Site-Specific Anticancer Effects of Dietary Flavonoid Quercetin

    Article • Nutrition and Cancer, December 2013, Taylor & Francis

    Dr. Katrin Sak

  90. Ace I/D polymorphism is associated with habitual physical activity in pubertal boys

    Article • The Journal of Physiological Sciences, August 2013, Springer Science + Business Media

    Dr. Katrin Sak

  91. Chemotherapy and Dietary Phytochemical Agents

    Article • Chemotherapy Research and Practice, December 2012, Hindawi Publishing Corporation

    Dr. Katrin Sak

  92. Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation

    Article • Journal of Neuro-Oncology, July 2012, Springer Science + Business Media

    Dr. Katrin Sak

  93. Genetic assessment following increased nuchal translucency and normal karyotype

    Article • Prenatal Diagnosis, February 2011, Wiley

    Dr. Katrin Sak

  94. Evaluation of the 124-plex SNP typing microarray for forensic testing

    Article • Forensic Science International Genetics, December 2009, Elsevier

    Dr. Katrin Sak

  95. Neuronal and glial cell lines as model systems for studying P2Y receptor pharmacology

    Article • Neurochemistry International, November 2005, Elsevier

    Dr. Katrin Sak

  96. The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis

    Article • Cellular and Molecular Life Sciences, October 2005, Springer Science + Business Media

    Dr. Katrin Sak

  97. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor

    Article • Biochemical Pharmacology, July 2005, Elsevier

    Dr Kenneth A. Jacobson, Dr. Katrin Sak

  98. Nongenomic effects of 17β-estradiol—diversity of membrane binding sites

    Article • The Journal of Steroid Biochemistry and Molecular Biology, April 2004, Elsevier

    Dr. Katrin Sak

  99. Involvement of P2Y receptors in the differentiation of haematopoietic cells

    Article • Journal of Leukocyte Biology, April 2003, Wiley

    Dr. Katrin Sak

  100. ‘Strain effect’ descriptors for ATP and ADP derivatives with modified phosphate groups

    Article • Computers & Chemistry, June 2002, Elsevier

    Dr. Katrin Sak

  101. A Retrospective of Recombinant P2Y Receptor Subtypes and Their Pharmacology

    Article • Archives of Biochemistry and Biophysics, January 2002, Elsevier

    Dr. Katrin Sak

  102. Pharmacological characterisation of pyrimidinoceptor responses in NG108-15 cells

    Article • European Journal of Pharmacology, March 2001, Elsevier

    Dr. Katrin Sak

  103. Are P2Y1 purinoceptors expressed in turkey erythrocytes?

    Article • Neuroscience Letters, October 2000, Elsevier

    Dr. Katrin Sak

  104. Phosphate-Substituted ATP Analogs Are Antagonists at Human P2Y1 Purinoceptors

    Article • Archives of Biochemistry and Biophysics, September 2000, Elsevier

    Dr. Katrin Sak

  105. Dual Effect of Nucleotides on P2Y Receptors

    Article • IUBMB Life, August 2000, Taylor & Francis

    Dr. Katrin Sak

  106. Dual Effect of Nucleotides on P2Y Receptors

    Article • IUBMB Life, August 2000, Wiley

    Dr. Katrin Sak

  107. Adenosine-Derived Non-Phosphate Antagonists for P2Y1 Purinoceptors

    Article • Biochemical and Biophysical Research Communications, June 2000, Elsevier

    Dr. Katrin Sak

  108. Adenosine triphosphate is full antagonist at human P2Y1 purinoceptors

    Article • Neuroscience Letters, April 2000, Elsevier

    Dr. Katrin Sak

  109. P2Y-receptor-ligand database

    Article • Trends in Biochemical Sciences, January 2000, Elsevier

    Dr. Katrin Sak

  110. Peptide phosphorylation by calcium-dependent protein kinase from maize seedlings

    Article • European Journal of Biochemistry, January 2000, Wiley

    Dr. Katrin Sak

  111. Modeling of the Amino Acid Side Chain Effects on Peptide Conformation

    Article • Bioorganic Chemistry, December 1999, Elsevier

    Dr. Katrin Sak

  112. Differential Specificity of Protein Kinases A and C in Reaction with Synthetic Peptides

    Article • Bioorganic Chemistry, June 1999, Elsevier

    Dr. Katrin Sak

  113. Only Pyrimidinoceptors Are Functionally Expressed in Mouse Neuroblastoma Cell Lines

    Article • Molecular Cell Biology Research Communications, June 1999, Elsevier

    Dr. Katrin Sak

  114. Pyrimidinoceptor potentiation by ATP in NG108-15 cells

    Article • FEBS Letters, November 1998, Wiley

    Dr. Katrin Sak

  115. Quantum chemical modelling of the effect of proline residues on peptide conformation

    Article • International Journal of Quantum Chemistry, January 1998, Wiley

    Dr. Katrin Sak

  116. Quantum chemical modelling of the effect of proline residues on peptide conformation

    Article • International Journal of Quantum Chemistry, January 1998, Wiley

    Dr. Katrin Sak

  117. Quantitative Structure–Activity Relationships in the Protein Kinase C Reaction with Synthetic Peptides Derived from Myelin Basic Protein

    Article • Bioorganic Chemistry, June 1996, Elsevier

    Dr. Katrin Sak